A long noncoding RNA connects c-Myc to tumor metabolism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 52, 2014, Pages 18697-18702

  Hung, Chiu Lien ^a   Wang, Ling Yu ^a   Yu, Yen Ling ^b   Chen, Hong Wu ^a   Srivastava, Shiv ^c   Petrovics, Gyorgy ^c   Kung, Hsing Jien ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

C Myc coactivator; LncRNA; Prostate cancer; Tumor metabolism

Indexed keywords

AMINO ACID; GLUCOSE; GLUTAMINE; LIPID; LONG UNTRANSLATED RNA; NUCLEOTIDE; PROSTATE CANCER GENE EXPRESSION MARKER 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; ANDROGEN RECEPTOR; MYC PROTEIN; MYC PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PCGEM1 NON-CODING RNA, HUMAN; RNA;

AEROBIC METABOLISM; AMINO ACID METABOLISM; ARTICLE; CANCER GROWTH; CELL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; FATTY ACID SYNTHESIS; GENE ACTIVATION; GENE CONTROL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPOGENESIS; LNCAP CELL LINE; MALE; METABOLIC REGULATION; NUCLEOTIDE METABOLISM; ONCOGENE C MYC; OXIDATION REDUCTION STATE; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSCRIPTION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PATHOLOGY; PROMOTER REGION; PROSTATE TUMOR; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

AEROBIOSIS; CELL LINE, TUMOR; GLYCOLYSIS; HEK293 CELLS; HUMANS; MALE; NADP; PENTOSE PHOSPHATE PATHWAY; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANDROGEN; RNA, LONG NONCODING; RNA, NEOPLASM;

EID: 84924590390     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1415669112     Document Type: Article

References (35)

1. Tsai MC, Spitale RC, Chang HY (2011) Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res 71(1):3-7.
2. Gibb EA, Brown CJ, Lam WL (2011) The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10:38.
3. Spizzo R, Almeida MI, Colombatti A, Calin GA (2012) Long non-coding RNAs and cancer: A new frontier of translational research? Oncogene 31(43):4577-4587.
4. Geisler S, Coller J (2013) RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14(11):699-712.
5. Srikantan V, et al. (2000) PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci USA 97(22):12216-12221.
6. Petrovics G, et al. (2004) Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23(2):605-611.
7. Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S (2006) Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 25(3):135-141.
8. Romanuik TL, et al. (2010) LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Med Genomics 3:43.
9. Yang L, et al. (2013) lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 500(7464):598-602.
10. Prensner JR, et al. (2014) The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget 5(6):1434-1438.
11. Massie CE, et al. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 30(13):2719-2733.
12. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85-95.
13. Ward PS, Thompson CB (2012) Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell 21(3):297-308.
14. Dang CV (2013) MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 3(8):a014217.
15. Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery DM (2009) c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 28(27):2485-2491.
16. Martinato F, Cesaroni M, Amati B, Guccione E (2008) Analysis of Myc-induced histone modifications on target chromatin. PLoS ONE 3(11):e3650.
17. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B (2001) Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15(16):2069-2082.
18. Dang CV (2012) Links between metabolism and cancer. Genes Dev 26(9):877-890.
19. Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491(7424):364-373.
20. Warburg O (1956) On the origin of cancer cells. Science 123(3191):309-314.
21. Newsholme EA, Crabtree B, Ardawi MS (1985) The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 5(5):393-400.
22. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930):1029-1033.
23. Beroukhim R, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899-905.
24. Ni M, et al. (2013) Amplitude modulation of androgen signaling by c-MYC. Genes Dev 27(7):734-748.
25. Bernard D, Pourtier-Manzanedo A, Gil J, Beach DH (2003) Myc confers androgen-independent prostate cancer cell growth. J Clin Invest 112(11):1724-1731.
26. Gao L, et al. (2013) Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation. PLoS ONE 8(5):e63563.
27. Papoulas O, Williams NG, Kingston RE (1992) DNA binding activities of c-Myc purified from eukaryotic cells. J Biol Chem 267(15):10470-10480.
28. Littlewood TD, Amati B, Land H, Evan GI (1992) Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7(9):1783-1792.
29. Guccione E, et al. (2006) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8(7):764-770.
30. Yang F, Zhang H, Mei Y, Wu M (2014) Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. Mol Cell 53(1):88-100.
31. Xiang JF, et al. (2014) Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res 24(5):513-531.
32. Yang F, et al. (2014) Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability. FEBS J 281(3):802-813.
33. Tennant DA, Durán RV, Gottlieb E (2010) Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 10(4):267-277.
34. Vander Heiden MG (2011) Targeting cancer metabolism: A therapeutic window opens. Nat Rev Drug Discov 10(9):671-684.
35. Kim RH, Bold RJ, Kung HJ (2009) ADI, autophagy and apoptosis: Metabolic stress as a therapeutic option for prostate cancer. Autophagy 5(4):567-568.